Status unknownNCT05753475Updated Mar 3, 2023

HOW DOES HEMODYNAMIC REGULATION AFFECTS GRAFT FUNCTIONS DURING RENAL TRANSPLANTATION?

An observational study in Renal Transplant Failure and Rejection and Hypotension, sponsored by Ankara City Hospital Bilkent. Status unknown at 1 site in Turkey. Open to participants aged 12 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-03-03.

Sponsored by Ankara City Hospital Bilkent · Observational

The sponsor has not verified this record recently (last verified Mar 2023), so the status shown — last known as Not yet recruiting — may be out of date.

Study type: Observational
Model: Cohort
Time perspective: Prospective
Enrollment: 100
Ages: 12 Years to 80 Years
Sex: All

Study summary

The aim of the researchers was to evaluate the adequacy of graft function in the postoperative period of patients who underwent renal transplantation and encountered hypotension in the intraoperative period.

Conditions studied

Renal Transplant Failure and Rejection
Hypotension

Browse trials for

Hypotension 1,003

In context

Hypotension

1,003 studies on the registry are indexed under Hypotension; 173 are open to participants now.

This study's planned enrollment of 100 is above the median of 84 across 294 observational studies indexed under Hypotension.

Browse Hypotension studies →

Lead sponsor

Ankara City Hospital Bilkent is the lead sponsor of 424 studies on the registry; 105 are open to participants now.

Counted across the registry records on this site, refreshed daily.

Who can participate

Ages eligible: 12 Years to 80 Years
Sexes eligible: All
Accepts healthy volunteers: Yes
Sampling method: Non-probability sample

Study population

patients undergoing renal transplantation

Inclusion criteria

patients undergoing renal transplantation

Exclusion criteria

Exclusion Criteria:

patient refusal

Study design

Observational model: Cohort
Time perspective: Prospective
Enrollment: 100 participants (estimated)
Target follow-up: 1 Year
Patient registry: Yes

Groups and cohorts

hypotension
Other: renal transplantation
normotension
Other: renal transplantation

Interventions

Otherrenal transplantation
patients undergoing renal transplantation

What researchers measure

Primary outcomes

Systolic Blood Pressure
Time frame: baseline
Mean Arterial Pressure
Time frame: baseline
Systolic Blood Pressure
Time frame: during the surgery
Mean Arterial Pressure
Time frame: during the surgery
graft function
Time frame: immediately after the surgery

Study locations

1 site

Ankara City Hospital
Ankara, 06800, Turkey

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

Updates

Tracking since Sep 25, 2026

No changes since tracking began. The registry record was last updated on Mar 3, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗

Registry details

Key details

Study ID: NCT05753475
Lead sponsor: Ankara City Hospital Bilkent
Responsible party: ismail aytaç (Principal investigator, Ankara City Hospital Bilkent) — Principal investigator
First posted: Mar 3, 2023
Start date: Mar 2023 (estimated)
Primary completion: Apr 2023 (estimated)
Completion: Feb 2024 (estimated)
Last update: Mar 3, 2023

Oversight

Data monitoring committee: No
FDA-regulated drug: No
FDA-regulated device: No

View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Hypotension→

Other studies from this sponsor

Ankara City Hospital Bilkent

Start the discussion